The epidemiology of invasive candidiasis has evolved in recent years, warranting a review
of the changes and the implications for current and future diagnosis and treatment. The …

Patients with suppressed immunity are at the highest risk for hospital-acquired infections.
Among these, invasive candidiasis is the most prevalent systemic fungal nosocomial …

The intestinal microbiota is a complex community of bacteria, archaea, viruses, protists and
fungi,. Although the composition of bacterial constituents has been linked to immune …

The number of immunosuppressive patients has increased significantly in recent years.
These patients are at risk for opportunistic infections, especially fungal infections …

Antibiotics are a modifiable iatrogenic risk factor for the most common human nosocomial
fungal infection, invasive candidiasis, yet the underlying mechanisms remain elusive. We …

This analysis describes the epidemiology and outcomes of invasive candidiasis caused by
non-albicans species of Candida in patients enrolled in the Prospective Antifungal Therapy …

Purpose To analyze trends in incidence and mortality of candidemia in intensive care units
(ICUs) vs. non-ICU hospitalized patients and to determine risk factors for infection by specific …

Background EUCAST has revised the definition of the susceptibility category I from
'Intermediate'to 'Susceptible, Increased exposure'. This implies that I can be used where the …

This analysis describes the epidemiology and outcomes of candidemia in patients enrolled
in the Prospective Antifungal Therapy Alliance (PATH Alliance®) registry from 2004 to 2008 …

Echinocandin resistance is increasingly encountered and its occurrence makes
susceptibility testing essential, particularly in patients with prior exposure. The further …